Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
13N-Ammonia
18F-DOPA
+2 more
Locations
1
United States
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Start Date
September 6, 2018
Primary Completion Date
December 31, 2028
Completion Date
December 31, 2029
Last Updated
April 20, 2026
NCT07330258
NCT05748028
NCT06508801
NCT02119611
NCT07310264
NCT04246437
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions